Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases, Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
J Ethnopharmacol. 2025 Jan 30;337(Pt 1):118791. doi: 10.1016/j.jep.2024.118791. Epub 2024 Sep 10.
Traditional Chinese medicine (TCM) has shown notable effectiveness and safety in managing illnesses linked to cytokine storm(CS). Bailixiang tea (BLX), an herbal medicine formula, which is a compound Chinese medicine composed of Thymus mongolicus (Ronniger) Ronniger (Bailixiang), Glycyrrhiza uralensis Fisch. (Gancao), Citrus reticulata Blanco (Chenpi), Cyperus rotundus L. (Xiangfu), and Perilla frutescens (L.) Britton (Zisu). The objective of this study was to explore the capacity of BLX in improving LPS-induced CS.
This study aimed to validate the mitigating effect of BLX on CS and to further investigate its mechanism.
mice were orally administered BLX for 24 h after being treated with 5 mg/kg lipopolysaccharide (LPS). Histopathological observations further confirmed the significant protective effect of BLX treatment against LPS-induced lung and spleen damage. Additionally, we aimed to explore the molecular mechanism underlying its effects through blood proteomics and transcriptomics analyses. Real-Time Quantitative PCR (RT-qPCR) was utilized to detect the levels of Toll-like receptor 2 (TLR2), Matrix metalloproteinase 8 (MMP8), Matrix metalloproteinase 9 (MMP9), Integrin beta 2 (ITGB2), Mitogen-activated protein kinase 8 (MAPK8), Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon (NFKBIE), Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (NFKB2), and Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH)expressions in the lung tissue.
The results demonstrated that BLX effectively down-regulated the overproduction of interleukin 6 (IL-6) and tumor necrosis factor-α (TNF-α) in both the serum and lung and spleen tissues. Furthermore, BLX effectively mitigated the overproduction of monocyte chemoattractant protein-1 (MCP-1) in the serum. Through comprehensive multi-omics analysis, it was revealed that BLX specifically targeted and regulated TLR2/MAPK8 and TLR2/NF-κB signaling pathways, which play a crucial role in the production of key cytokines.
The findings of this study demonstrate that Bailixiang tea possesses the ability to alleviate lung tissue damage and inhibit the development of LPS-induced cytokine storm in mice. These effects are attributed to the tea's ability to suppress the TLR2/MAPK8 and TLR2/NF-κB pathways. Consequently, this research highlights the potential application of Bailixiang tea as a treatment option for cytokine storm.
ETHNOPHARMACOLOGICAL 相关性:传统中药(TCM)在管理与细胞因子风暴(CS)相关的疾病方面显示出显著的疗效和安全性。百令香茶(BLX)是一种草药配方,是由蒙古百里香(Ronniger) Ronniger(百令香)、甘草(甘草)、柑橘(陈皮)、香附(香附)和紫苏(紫苏)组成的复方中药。本研究旨在探讨 BLX 改善 LPS 诱导的 CS 的能力。
本研究旨在验证 BLX 对 CS 的缓解作用,并进一步探讨其机制。
用 5mg/kg 脂多糖(LPS)处理后,小鼠口服 BLX 24 小时。组织病理学观察进一步证实了 BLX 治疗对 LPS 诱导的肺和脾损伤的显著保护作用。此外,我们旨在通过血液蛋白质组学和转录组学分析来探讨其作用的分子机制。实时定量 PCR(RT-qPCR)用于检测 Toll 样受体 2(TLR2)、基质金属蛋白酶 8(MMP8)、基质金属蛋白酶 9(MMP9)、整合素β 2(ITGB2)、丝裂原活化蛋白激酶 8(MAPK8)、κ 轻链基因增强子核因子 B 抑制剂,ε(NFKBIE)、κ 轻链基因增强子核因子 B2(NFKB2)和甘油醛-3-磷酸脱氢酶(GAPDH)在肺组织中的表达。
结果表明,BLX 能有效下调血清及肺、脾组织中白细胞介素 6(IL-6)和肿瘤坏死因子-α(TNF-α)的过度产生。此外,BLX 能有效减轻血清中单核细胞趋化蛋白-1(MCP-1)的过度产生。通过综合多组学分析,发现 BLX 特异性靶向和调节 TLR2/MAPK8 和 TLR2/NF-κB 信号通路,这些通路在关键细胞因子的产生中起关键作用。
本研究表明,百令香茶具有减轻肺组织损伤和抑制 LPS 诱导的细胞因子风暴小鼠发病的能力。这些作用归因于茶抑制 TLR2/MAPK8 和 TLR2/NF-κB 通路的能力。因此,本研究强调了百令香茶作为细胞因子风暴治疗选择的潜力。